Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 54, 2019 - Issue 9
Submit an article Journal homepage
123
Views
1
CrossRef citations to date
0
Altmetric
Original Article

The relationship between IFNL4 genotype and the rate of fibrosis in hepatitis C patients

Rachna Shridhar GulatiDepartment of Infectious Diseases, Akershus University Hospital, Nordbyhagen, Norway;
,
Thakshani WimalanathanDepartment of Infectious Diseases, Akershus University Hospital, Nordbyhagen, Norway;
,
Solveig Norheim AndersenDepartment of Pathology, Akershus University Hospital, Nordbyhagen, Norway;
,
Kjetil IsaksenDepartment of Medicine, Stavanger University Hospital, Stavanger, Norway;
,
Martin LaggingSahlgrenska University Hospital, Gothenburg, Sweden; ORCID Iconhttp://orcid.org/0000-0002-7995-3626
ORCID Icon,
Håvard MidgardUllevål University Hospital, Oslo, Norway;
,
Amir MoghaddamDepartment of Infectious Disease, Fürst Medical Laboratory, Oslo, Norway
&
Olav DalgardDepartment of Infectious Diseases, Akershus University Hospital, Nordbyhagen, Norway; Correspondence[email protected]
 show all
Pages 1172-1175 | Received 01 May 2019, Accepted 08 Jul 2019, Published online: 03 Sep 2019

References

  • Messina J, Humphreys I, Flaxman A, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61:77–87.
  • Lange C, Zeuzem S. IL28B single nucleotide polymorphisms in the treatment of hepatitis C. J Hepatol. 2011;55:692–701.
  • Berger C, Kim A. IL28B polymorphisms as a pretreatment predictor of response to HCV treatment. Infect Dis Clin North Am. 2012;26:863–877.
  • Ge D, Fellay J, Thompson A, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461:399–401.
  • Gupta A, Trehanpati N, Sukriti S, et al. Interleukin-28b CC genotype predicts early treatment response and CT/TT genotypes predicts non-response in patients infected with HCV genotype 3. J Med Virol. 2014;86:707–712.
  • Pár A, Pár G, Tornai I, et al. IL28B CC genotype: a protective factor and predictor of the response to interferon treatment in chronic hepatitis C virus infection. Orv Hetil. 2013;154:1261–1268.
  • Moghaddam A, Melum E, Reinton N, et al. IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection. Hepatology. 2011;53:746–754.
  • Ydreborg M, Westin J, Rembeck K, et al. Impact of IL28B-related single nucleotide polymorphisms on liver transient elastography in chronic hepatitis C infection. PLoS ONE. 2013;8:e80172.
  • Rembeck K, Alsiö Å, Christensen P, et al. Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3. PLoS ONE. 2012;7:e29370.
  • D'Ambrosio R, Aghemo A, De Francesco R, et al. The association of Il28b genotype with the histological features of chronic hepatitis C is HCV genotype dependent. IJMS. 2014;15:7213–7224.
  • Lundbo L, Clausen L, Weis N, et al. Influence of hepatitis C virus and IL28B genotypes on liver stiffness. PLoS One. 2014;9:e115882.
  • Goodman Z. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007;47:598–607.
  • Mohamadnejad M, Tavangar SM, Sotoudeh M, et al. Histopathological study of chronic hepatitis B: a comparative study of Ishak and METAVIR Scoring Systems. Int J Org Transplant Med. 2010;1:171–176.
  • The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994;20:15–20.
  • Anand V, Hyun C, Khan Q, et al. Identification and fibrosis staging of hepatitis C patients using the electronic medical record system. J Clin Gastroenterol. 2016;50:664–669.
  • Shiha G, Zalata K. Ishak versus METAVIR: Terminology, Convertibility and Correlation with Laboratory Changes in Chronic Hepatitis C. In: Hirokazu Takahashi, editor. Liver Biopsy. London (UK): InTech; 2011. Available from: http://www.intechopen.com/books/liver-biopsy/ishak-versus-metavir-terminology-convertibility-and-correlation-with-laboratory-changes-in-chronic-h
  • Czaja A. Hepatic inflammation and progressive liver fibrosis in chronic liver disease. WJG. 2014;20:2515–2532.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.